{"id":"NCT00522951","sponsor":"Bayer","briefTitle":"SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study","officialTitle":"Multi-center, Randomized, Controlled, Single-blind, Intra-individual Comparisons of 2 Dose of Gadobutrol 1.0 Molar and Gadoteridol (ProHance) Crossover Studies With Corresponding Blinded Image Evaluation Following Multiple Injections of 0.1 mmol/kg bw of Gadobutrol and Gadoteridol in Patients With Known or Suspected Brain Metastasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2008-08","completion":"2008-08","firstPosted":"2007-08-30","resultsPosted":"2011-08-03","lastUpdate":"2017-08-28"},"enrollment":165,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Brain Metastases"],"interventions":[{"type":"DRUG","name":"Gadobutrol (Gadavist, Gadovist, BAY86-4875)","otherNames":[]},{"type":"DRUG","name":"Gadobutrol (Gadavist, Gadovist, BAY86-4875)","otherNames":[]},{"type":"DRUG","name":"ProHance","otherNames":[]}],"arms":[{"label":"Gadobutrol 0.1 mmol/kg bw","type":"EXPERIMENTAL"},{"label":"Gadobutrol 0.2 mmol/kg bw","type":"EXPERIMENTAL"},{"label":"Gadoteridol (ProHance)","type":"EXPERIMENTAL"}],"summary":"This study is conducted to compare the contrast effect and safety of SH L562BB with ProHance, which has already been approved as a pharmaceutical product of similar indication.","primaryOutcome":{"measure":"Number of Lesions Detected by Blinded Readers (BR) and Investigator","timeFrame":"one day","effectByArm":[{"arm":"Gadobutrol 0.1 mmol/kg bw","deltaMin":6.28,"sd":8.31},{"arm":"Gadobutrol 0.2 mmol/kg bw","deltaMin":6.92,"sd":8.69},{"arm":"Gadoteridol (ProHance) 0.2mmol/kg bw","deltaMin":6.87,"sd":8.65}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":20,"countries":["Japan"]},"refs":{"pmids":["21467949"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":161},"commonTop":["Vomiting","Rash","Nausea","Glucose urine present","Headache"]}}